Nalls Sherbakoff Group, LLC Fulgent Genetics, Inc. Transaction History
Nalls Sherbakoff Group, LLC
- $112 Billion
- Q4 2023
A detailed history of Nalls Sherbakoff Group, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Nalls Sherbakoff Group, LLC holds 100 shares of FLGT stock, worth $1,851. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$1,851
Previous $2.67 Million
8.12%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding FLGT
# of Institutions
200Shares Held
16MCall Options Held
2.04MPut Options Held
14K-
Black Rock Inc. New York, NY3.92MShares$72.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$26.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$23.5 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.11MShares$20.5 Million0.01% of portfolio
-
State Street Corp Boston, MA794KShares$14.7 Million0.0% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $560M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...